Effects of Strain and Age on Ear Wound Healing and Regeneration in Mice

    Raquel Alves Costa, Valéria Ruiz-de-Souza, Geraldo Magela de Azevedo, Nelson M. Vaz, Celso Morato de Carvalho
    Image of study
    TLDR Young C57BL/6 mice heal better than BALB/c mice, and older mice heal faster but regenerate worse.
    The study explored how strain and age affect ear wound healing and regeneration in mice, comparing young (8 weeks old) C57BL/6 and BALB/c mice to middle-aged (40 weeks old) C57BL/6 mice. Results showed that by day 100, young C57BL/6 mice had a higher percentage of wound closure (56.47 ± 7.39%) compared to young BALB/c mice (23.57 ± 8.66%), and middle-aged C57BL/6 mice had the highest closure rate (75.31 ± 23.65%). However, the greater wound closure in middle-aged mice did not correspond to better regeneration, as they exhibited reduced regenerative processes and no new hair follicles or sebaceous glands. Young C57BL/6 mice demonstrated better tissue reorganization and regeneration, including more organized collagen fibers and extensive cartilage formation. The study concluded that young mice of both strains showed signs of regeneration, with young C57BL/6 mice having superior regenerative characteristics compared to BALB/c mice, and that aging impairs the regenerative capacity in mice.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 1000+ results

      community Verteporfin day 119 update - donor hair regeneration human trial

      in Research/Science  148 upvotes 2 years ago
      A human trial of verteporfin, a drug that can inhibit wound healing by scarring and promote regeneration of original tissue and hair follicles to provide an unlimited source for hair transplants; people discussed the potential of this drug and how it could be rolled out in mainstream with more doctors getting on board.

      community Verteporfin and Microneedling

      in Treatments 6 months ago
      Clinical studies by Dr. Barghouthi and Dr. Bloxham indicate that Verteporfin, when used with FUE and FUT hair transplantation methods, shows promise in hair follicle regeneration and minimal scarring due to its ability to inhibit Yes-associated protein (YAP). Microneedling at depths of 3-3.5mm, combined with Verteporfin, could potentially reactivate dormant follicles, although the optimal dosage and application method are still under investigation. Concerns remain about the DHT sensitivity of regenerated follicles, highlighting the need for further research to optimize trauma levels and Verteporfin concentrations to achieve effective and scar-free hair regeneration.

      community HAIR REGENERATION HUMAN TRIALS with Verteporfin

      in Research/Science  12 upvotes 2 years ago
      A new human trial using an FDA-approved treatment for wound healing called Verteporfin, which may potentially be able to reverse scarring and regrow hair in that area. The trial is only lasting one month so far.

    Similar Research

    5 / 1000+ results